Symptom Clusters in Children With Leukemia
Completed
- Conditions
- Childhood Leukemia
- Registration Number
- NCT01708421
- Lead Sponsor
- Duke University
- Brief Summary
The purpose of this study is to examine the phenotypic and genotypic characteristics and their associations with symptom clusters experienced during treatment for childhood leukemia.
- Detailed Description
A repeated measures research design will evaluate phenotypic and genotypic treatment-related symptom associations experienced by children and adolescents 3-17 years of age with a diagnosis of leukemia.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 338
Inclusion Criteria
- Phenotypic and genotypic treatment-related symptom associations will be evaluated in children and adolescents 3-18 years of age with a diagnosis of leukemia.
Exclusion Criteria
- Children without a definite diagnosis of leukemia will be excluded.
- Children must be able to understand and answer the questions on the questionnaires.
- Children with have a cognitive impairment (e.g. Down syndrome) will not be able to complete the questionnaires and will not be eligible for the study.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (4)
University of Arizona
🇺🇸Tucson, Arizona, United States
Children's Hospitals & Clinics of Minnesota
🇺🇸Minneapolis, Minnesota, United States
Duke University Medical Center
🇺🇸Durham, North Carolina, United States
Baylor College of Medicine/ Texas Children's Cancer Center
🇺🇸Houston, Texas, United States
University of Arizona🇺🇸Tucson, Arizona, United States